David Cohn
InvestorInterim Chief Executive Officer and Chief Medical Officer at Oncology Ventures
Columbus, Ohio, United States
About
Physician and gynecologic oncologist leading a cancer hospital's strategic direction. An NCI-funded scientist with 300+ published manuscripts. Member of the Limited Partner Advisory Committee.
Experience
- Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research InstituteChief Operating Officercurrent2025 β presentColumbus, OH
- Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research InstituteGynecologic Oncologistcurrent2001 β presentColumbus, Ohio, United States
- Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research InstituteChief Medical Officer2018 β 2026Columbus, OH
- Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research InstituteInterim Chief Executive Officer2022 β 2025Columbus, Ohio, United States
Education
- The Ohio State University Moritz College of LawMaster of Laws2025 β 2027
- The Ohio State University Fisher College of BusinessMBA2018 β 2020
- Washington University School of Medicine in St. LouisGynecologic Oncology Fellowship Program1998 β 2001
- University of Washington - School of MedicineObstetrics and Gynecology Residency Program1994 β 1998
- Georgetown University School of MedicineDoctor of Medicine - MD1990 β 1994
- University of Michigan College of Literature, Science, and the ArtsBachelor of Science - BS, Biologic Psychology1985 β 1989
Same school
Also attended The Ohio State University Fisher College of Business37
Keatten SmithCapital Formation Coordinator at March Capital PartnersSachi SanghaviJunior Analyst at JobsOhio VenturesBrandon BryantInvestor at Harlem Capital PartnersDavid MalloyAssociate at Tech Square VenturesJason KaliraPartner at The Westly GroupMichael Anthony-WoodFinance Associate at Red Cell Incubation
+ 31 more
Also attended University of Washington - School of Medicine9
Uri LopatinInvestor at Khosla VenturesDennis SchmulandInvestor at EPIC VENTURESChing-Ping LinPartner & COO at Orbit StartupsJulien PhamFounder & Managing Partner at 3CC | Third Culture CapitalMitch GoldVenture Partner at Frazier Life SciencesAmy PollackIndependent Consultant and Board Member at Foreground Capital
+ 3 more
Also attended Georgetown University School of Medicine2
Also attended University of Michigan College of Literature, Science, and the Arts11
Isabel GlassChief of Staff & Investor at Cade VenturesBeri LantumInvestor at Silversmith Capital PartnersAbi Gold-PastorOperations Associate at OutsidersJonah SklarTechnical Advisor at Untapped VenturesMeagan MalmPartner & Director of Operations at Michigan Capital NetworkAngel MartinSenior Associate at Frazier Life Sciences
+ 5 more
Colleagues at Oncology Ventures
Ben Freeberg
Founder, Managing Partner at Oncology Ventures
Brad Hively
Advisor at Oncology Ventures
Carolyn Starrett
Advisor at Oncology Ventures
Diana Verrilli
General Manager, Navista (a Cardinal Health company) at Oncology Ventures
Emily Melton
Investor at Threshold Ventures
Harlan Levine
President of Health Innovation and Policy at Oncology Ventures
Jason Shook
Chief Operating Officer at Oncology Ventures
Jay Freeberg
Chief Financial Officer at Oncology Ventures


























